Results and analysis of an intercomparisons study for individual monitoring services of Latin American and Caribbean regions.

The aim of this paper is to present the results obtained by the Latin-American and Caribbean personal dosimetry services that participated, with the support of IAEA, in the 2020-Eurados whole-body dosemeter intercomparison for photon radiation. All participant services in this study use thermoluminescent dosimetry (TLD) systems except one that uses optically stimulated luminescence (OSL) dosemeters. Data analysis shows that 93.4% of the results are within the acceptance range, according to International ISO Standard ISO 14146: 2018. The evaluation of the trumpet curves shows that only three laboratories presented a few dosemeters results outside the limits of acceptability. Participation in this Eurados intercomparison exercise gave the Latin American and Caribbean laboratories the opportunity to show compliance with their own quality management system, to compare results with other participants and to develop plans for improving their dosimetry systems. It also gave the assurance that occupational doses are being measured properly and following the international standards in the regions.

Measurements of air kerma index in computed tomography: A comparison among methodologies.

As CT exams impart high doses to patients in comparison to other radiologist techniques, reliable dosimetry is required. In this work, dosimetry in CT beams was carried out in terms of air kerma index in air or in a phantom measured by a pencil ionization chamber, thermoluminescent (TL) detectors and radiochromic film. Calibration results showed the low energy dependence of all three dosimetric systems for the 100-120kV range, the very high uncertainty of the TL dosimeters in comparison to the other systems and high nonlinearity response in terms of air kerma of the radiochromic film. Measurements with the three systems in a 120kV CT protocol showed an acceptable agreement among the weighted air kerma index values, but TL dosimeters presented the highest uncertainties in the values.

Assessment of breast absorbed doses during thoracic computed tomography scan to evaluate the effectiveness of bismuth shielding.

During a lung computed tomography (CT) examination, breast and nearby radiosensitive organs are unnecessarily irradiated because they are in the path of the primary beam. The purpose of this paper is to determine the absorbed dose in breast and nearby organs for unshielded and shielded exposures with bismuth. The experiment was done with a female anthropomorphic phantom undergoing a typical thoracic CT scan, with TLD-100 thermoluminescent detectors insert at breast, lung and thyroid positions. Results showed that dose reduction due to bismuth shielding was approximately 30% and 50% for breast and thyroid, respectively; however, the influence of the bismuth on the image quality needs to be considered.

Suggestion of a national diagnostic reference level for 18F-FDG/PET scans in adult cancer patients in Brazil / Sugestão de nível de referência em diagnóstico nacional para 18F-FDG/PET em procedimentos oncológicos adultos no Brasil

Objective To suggest a national value for the diagnostic reference level (DRL) in terms of activity in MBq.kg–1, for nuclear medicine procedures with fluorodeoxyglucose (18F-FDG) in whole body positron emission tomography (PET) scans of adult patients. Materials and Methods A survey on values of 18F-FDG activity administered in Brazilian clinics was undertaken by means of a questionnaire including questions about number and manufacturer of the installed equipment, model and detector type. The suggested DRL value was based on the calculation of the third quartile of the activity values distribution reported by the clinics. Results Among the surveyed Brazilian clinics, 58% responded completely or partially the questionnaire; and the results demonstrated variation of up to 100% in the reported radiopharmaceutical activity. The suggested DRL for 18F-FDG/PET activity was 5.54 MBq.kg–1 (0.149 mCi.kg–1). Conclusion The present study has demonstrated the lack of standardization in administered radiopharmaceutical activities for PET procedures in Brazil, corroborating the necessity of an official DRL value to be adopted in the country. The suggested DLR value demonstrates that there is room for optimization of the procedures and 18F-FDG/PET activities administered in Brazilian clinics to reduce the doses delivered to patients. It is important to highlight that this value should be continually revised and optimized at least every five years. .

Evaluation of a technique for in vivo internal monitoring of (18)F within a Brazilian laboratory network.

(18)FDG, an analogue of glucose labelled with the radionuclide (18)F, is the most widely used radiopharmaceutical in positron emission tomography/computed tomography technique. In Brazil, there are currently eight (18)FDG plants in operation and other facilities are expected to start their production in the near future. The growth in the production and clinical use of (18)FDG represents an increasing risk of worker exposures. According to national regulations and international recommendations, internal exposures should be effectively controlled in order to keep doses as low as possible. The implementation of a routine monitoring programme towards the estimation of internal doses related to the incorporation of (18)F is difficult, mainly due to its short physical half-life, the cost of a bioassay laboratory and the need of a monitoring service promptly available near the production plant. This paper describes the implementation and evaluation of a methodology for in vivo brain monitoring of (18)F to be applied in cases of suspected incorporation of (18)FDG. The technique presented a minimum detectable effective dose in the order of nanoSieverts, which allows its application for occupational monitoring purposes.